Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data. The post The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience appeared first on MedCity News.
CMS is proposing to make its joint replacement bundled payment model mandatory nationwide. Experts say it is a logical step, but warn that mandatory participation could be challenging for hospitals to implement. The post Expanding the CJR Model Is a Logical Step in VBC, but Implementation Challenges Remain appeared first on MedCity News.
Healthcare leaders hope Dr. Oz supports Medicare Advantage, nutrition and telehealth as CMS administrator. The post What Issues Do Healthcare Leaders Want Dr. Oz to Tackle as CMS Administrator? appeared first on MedCity News.
This brief analyzes federal transparency data published by CMS on claims denials and appeals for Marketplace plan offered on HealthCare.gov in 2024, and finds insurers denied 19% of in-network claims. Consumers rarely appeal denied claims.
This issue brief examines Medicaid expansion enrollment and Medicaid spending in expansion and non-expansion states and describes the characteristics of adults covered by the Medicaid expansion.
Povetacicept, a Vertex Pharmaceuticals immunology drug designed to block two targets, met the main goal of a Phase 3 clinical trial in the rare kidney disease immunoglobulin A nephropathy. The fusion protein came from Vertex’s acquisition of Alpine Immune Sciences, and analysts say the drug has best-in-class potential. The post Vertex Pharma to Seek Speedy…
GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma’s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concerns from U.S. and European regulators. The post Alfasigma Pays $300M for Rights to GSK Rare Liver…
APG CEO Susan Dentzer believes that now is indeed the time to act to improve Medicare and Medicare Advantage
El médico de familia Eric Boose ha estado usando una herramienta de inteligencia artificial (IA) para volver a lo que él llama la “medicina a la antigua”: hablar con los pacientes cara a cara, sin tener que escribir en una computadora al mismo tiempo. “Realmente puedo sentarme, interactuar, concentrarme en ellos y escuchar”, dijo Boose,…
That is the title of a new paper out yesterday in the Journal of Diabetes Science and Technology from my FTI colleague Marie Steele-Adjognon, along with Martha E. Shepherd, Jon Harris-Shapiro, David Hines, Abraham Lee and Yeesha Poon. The abstract is below. Background: This study evaluated the impact of continuous glucose monitoring (CGM) on health…